FrancophonIA/ELRC3.0 huggingface dataset:
English: 0.5 ml in pre-filled syringe (type I glass) with a plunger stopper (butyl) for 1 dose - pack sizes of 1 and 10 with or without needles.
Danish: 0,5 ml i fyldt injektionssprøjte (type I-glas) med stempelprop (butyl) til 1 dosis - pakningsstørrelser på 1 og 10 med eller uden kanyle.
English: In this clinical study, the immunogenicity of the monovalent aluminium-adjuvanted whole virus vaccine (A/H5N1) with a haemagglutinin content of 27µg HA per dose in adults aged 18-60 years (N=49) was also evaluated following a 0, 21 day schedule.
Danish: I dette kliniske forsøg blev immunogeniciteten af den monovalente, aluminiumsadjuverede, hele virusvaccine (A/H5N1) med et hæmagglutininindhold på 27 µg HA pr. dosis til voksne i alderen 1860 år (N=49), der har fået vaccinen på dag 0 og dag 21, også vurderet.
English: No data have been generated with Daronrix below 18 years of age.
Danish: Der foreligger ingen data om Daronrix givet til personer under 18 år.
English: The vaccine should be allowed to reach room temperature before use.
Danish: Vaccinen bør have stuetemperatur, når den anvendes.
English: What Daronrix looks like and contents of the pack
Danish: Daronrix' udseende og pakningsstørrelse
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 20 doses (10 ml)
Danish: INDHOLDSMÆNGDE ANGIVET SOM VÆGT, VOLUMEN ELLER ANTAL DOSER 20 doser (10 ml)
English: Suspension for injection Vial
Danish: Intramuskulær anvendelse
English: What Daronrix is and what it is used for Before you receive Daronrix How Daronrix is given Possible side effects How to store Daronrix Further information
Danish: Daronrix' virkning og hvad du skal bruge det til Det skal du vide, før du begynder at bruge Daronrix.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS MONODOSE PRESENTATION
Danish: MINDSTEKRAV TIL OPLYSNINGER, DER SKAL ANFØRES PÅ SMÅ INDRE EMBALLAGER
English: Pandemic influenza vaccine (whole virion, inactivated, adjuvanted)
Danish: Pandemisk influenzavaccine (hele virion, inaktiveret, adjuveret) Intramuskulært
English: Daronrix is a white, slightly milky liquid and is presented in a pre-filled syringe (0.5 ml) for 1 dose in pack sizes of 1 and 10 with or without needles
Danish: Daronrix er en hvid, let mælkeagtig væske og kommer i en fyldt sprøjte (0,5 ml) med 1 dosis i pakningsstørrelser på 1 og 10 med eller uden kanyler.
English: HOW TO STORE DARONRIX
Danish: SÅDAN OPBEVARER DU DARONRIX
English: After administration of Daronrix, it is unlikely that side effects would unable you to drive or use machines.
Danish: Det er usandsynligt, at der vil komme bivirkninger, som skulle gøre dig ude af stand til at køre bil eller anvende maskiner.
English: 5 ml in ampoule (type I glass) for 10 doses - pack size of 50
Danish: 5 ml i ampul (type I-glas) til 10 doser - pakningsstørrelse på 50
English: Important information about some of the ingredients of Daronrix Thiomersal (preservative) is present in this product, and it is possible that you may experience an allergic reaction.
Danish: Dette produkt indeholder et konserveringsmiddel kaldet Thiomersal , og du kan derfor få en allergisk reaktion.
English: In consequence, as soon as the pandemic is declared (Phase 6 of the WHO global Influenza preparedness plan) and the pandemic vaccine is used, the MAH shall submit periodic safety update reports with periodicity and format defined as follows:
Danish: Som en konsekvens heraf skal indehaveren af markedsføringstilladelsen indsende regelmæssige PSUR på nedennævnte tidspunkter og i nedenfor anførte format, så snart pandemien er erklæret (fase 6 i WHO's beredskabsplan for verdensomspændende influenza) og pandemivaccinen anvendt.
English: Daronrix should not be given:
Danish: Tag ikke Daronrix:
English: ♦ Very rare (less than 1 per 10,000 doses of vaccine):
Danish: ♦ Meget sjælden (forekommer hos færre end 1 ud af 10.000 patienter):
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 10 doses (5 ml)
Danish: INDHOLDSMÆNGDE ANGIVET SOM VÆGT, VOLUMEN ELLER ANTAL DOSER 10 doser (5 ml)
English: • if you have previously had any allergic reaction to Daronrix, or any ingredient (including eggs, chicken protein, gentamicin sulphate (antibiotic)) contained in this vaccine.
Danish: • hvis du tidligere har haft en allergisk reaktion mod Daronrix eller et af indholdsstofferne (inkl.
English: ♦ Very common (more than 1 per 10 doses of vaccine):
Danish: ♦ Meget almindelig (forekommer hos flere end 1 ud af 10 patienter):
English: Data obtained with the mock-up vaccine will support a vaccination strategy that is likely to be used for the pandemic vaccine: clinical immunogenicity, safety and reactogenicity data obtained with mock-up vaccines are relevant for the pandemic vaccines.
Danish: Data fra mockup-vaccinationer støtter den vaccinationsstrategi, der sandsynligvis vil blive anvendt med den pandemiske vaccine.
English: Allergic reactions, in rare cases leading to shock, have been reported.
Danish: Neuralgi, paræstesi, konvulsioner, forbigående trombocytopeni Der er indberettet allergiske reaktioner, som i sjældne tilfælde kan føre til chok.
English: - If you have any further questions, ask your doctor or pharmacist.
Danish: - Spørg lægen eller på apoteket, hvis der er mere, du vil vide.
English: Marketing Authorisation Holder
Danish: MARKEDSFØRINGSTILLADELSEN
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING MONODOSE PRESENTATION
Danish: OPLYSNINGER, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE ENKELTDOSISBEHOLDER
English: Pandemic influenza vaccine should be used in accordance with official guidance.
Danish: Pandemisk influenzavaccine bør anvendes i overensstemmelse med officielle retningslinjer (se afsnit 4.2 og 5.1).
English: 50 x 10 doses 1 dose (0.5 ml)
Danish: 50 x 10 doser 1 dosis (0,5 ml)
English: 10 x 1 dose 1 dose (0.5 ml)
Danish: 10 x 1 dosis 1 dosis (0,5 ml)
English: BEFORE YOU RECEIVE DARONRIX
Danish: DET SKAL DU VIDE, FØR DU BEGYNDER AT BRUGE DARONRIX
English: 50 x 20 doses 1 dose (0.5 ml)
Danish: Hætteglas 50 x 20 doser 1 dosis (0,5 ml)
English: 10 ml in vial (type I glass) for 20 doses - pack size of 50
Danish: 5 ml i hætteglas (type I-glas) til 10 doser - pakningsstørrelse på 50 10 ml i hætteglas (type I-glas) til 20 doser - pakningsstørrelse på 50
English: AMPOULE (10 DOSES) X 50
Danish: FLERDOSISBEHOLDER HÆTTEGLAS (10 DOSER) X 50 HÆTTEGLAS (20 DOSER) X 50 AMPUL (10 DOSER) X 50
English: PHARMACEUTICAL FORM Suspension for injection.
Danish: LÆGEMIDDELFORM Injektionsvæske, suspension Uklar, hvis suspension.
English: Vial
Danish: Ampul
English: Turbid white suspension.
Danish: LÆGEMIDDELFORM Injektionsvæske, suspension Uklar, hvid suspension.
English: ♦ Common (less than 1 per 10 but more than 1 per 100 doses of vaccine):
Danish: ♦ Almindelig (forekommer hos mellem 1 og 10 ud af 100 patienter):
English: please tell your doctor or pharmacist.
Danish: Spørg din læge eller apoteket til råds, før du tager nogen form for medicin.
English: Daronrix, suspension for injection in pre-filled syringe Pandemic influenza vaccine (whole virion, inactivated, adjuvanted)
Danish: Daronrix, injektionsvæske, suspension Pandemisk influenzavaccine (hele virion, inaktiveret, adjuveret)
English: ♦ Uncommon (less than 1 per 100 but more than 1 per 1000 doses of vaccine):
Danish: ♦ Ikke almindelig (forekommer hos mellem 1 og 10 ud af 1.000 patienter):
English: Daronrix, suspension for injection in multidose container Pandemic influenza vaccine (whole virion, inactivated, adjuvanted)
Danish: Daronrix, injektionsvæske, suspension, flerdosisbeholder Pandemisk influenzavaccine (hele virion, inaktiveret, adjuveret)
English: For a full list of excipients see section 6.1.
Danish: Alle hjælpestoffer er anført under punkt 6.1.
English: Uncommon (≥1/1,000 to <1/100): Generalised skin reactions including pruritus, urticaria or non-specific rash.
Danish: Ikke almindelig (≥ 1/1.000, < 1/100) Generaliserede hudreaktioner inkl.
English: ♦ Rare (less than 1 per 1000 but more than 1 per 10,000 doses of vaccine):
Danish: ♦ Sjælden (forekommer hos mellem 1 og 10 ud af 10.0000 patienter):
English: • Increased sweating, bruising
Danish: • Øget svedproduktion, blå mærker
English: One of the active substances, palonosetron, has been authorised on its own in the EU since 2005.
Danish: Et af de aktive stoffer, palonosetron, har selvstændigt været godkendt i EU siden 2005.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Akynzeo on 27 May 2015
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Akynzeo den 27. maj 2015.
English: The patient takes one capsule one hour before starting each chemotherapy cycle.
Danish: Patienten tager én kapsel en time før start af hver kemoterapicyklus.
English: Akynzeo netupitant / palonosetron hydrochloride
Danish: Akynzeo netupitant/palonosetronhydrochlorid
English: This is a summary of the European public assessment report (EPAR) for Akynzeo.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Akynzeo.
English: The full EPAR and risk management plan summary for Akynzeo can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR og resuméet af risikostyringsplanen for Akynzeo findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The Committee therefore concluded that the medicine's benefits are greater than its risk and recommended that it be approved for use in the EU.
Danish: Udvalget konkluderede derfor, at fordelene ved lægemidlet opvejer risiciene, og anbefalede, at det godkendes til anvendelse i EU.
English: A risk management plan has been developed to ensure that Akynzeo is used as safely as possible.
Danish: Der er udarbejdet en risikostyringsplan for at sikre, at Akynzeo anvendes så sikkert som muligt.
English: The figures for day 2 to day 5 were 77% for patients in the Akynzeo group and 70% for those in the palonosetron group.
Danish: Tallene for dag 2 til dag 5 var 77 % for patienter i Akynzeo-gruppen og 70 % for patienter i palonosetron-gruppen.
English: Other information about Akynzeo
Danish: Andre oplysninger om Akynzeo
English: This study involved 1,455 patients and the patients took dexamethasone, another medicine used to prevent vomiting, as an additional treatment.
Danish: Denne undersøgelse involverede 1455 patienter, og patienterne tog som en ekstra behandling dexamethason, et andet lægemiddel, der anvendes til at forhindre opkastning.
English: The most common side effects reported with Akynzeo are headache (seen in 3.6% of patients), constipation (3.0%) and fatigue (1.2%).
Danish: De hyppigste bivirkninger, der er indberettet med Akynzeo, er hovedpine (set hos 3,6 % af patienterne), forstoppelse (3,0 %) og træthed (1,2 %).
English: Akynzeo is available as capsules containing 300 mg of netupitant and 0.5 mg of palonosetron.
Danish: Akynzeo fås som kapsler, der indeholder 300 mg netupitant og 0,5 mg palonosetron.
English: What measures are being taken to ensure the safe and effective use of Akynzeo?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Akynzeo?
English: Around 88% of patients taking Akynzeo experienced no vomiting on day 1 following the first chemotherapy cycle, compared with 85% of patients taking palonosetron.
Danish: Cirka 88 % af de patienter, der tog Akynzeo, oplevede ingen opkastning på dag 1 efter den første kemoterapicyklus, sammenlignet med 85 % af patienter, der tog palonosetron.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Akynzeo, including the appropriate precautions to be followed by healthcare professionals and patients.
Danish: På baggrund af denne er der anført sikkerhedsoplysninger i produktresuméet og indlægssedlen for Akynzeo, herunder passende forholdsregler, som patienter og sundhedspersonale skal følge.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) noted that Akynzeo was effective at preventing both the immediate and delayed phases of nausea and vomiting following chemotherapy, and that the medicine has a favourable safety profile.
Danish: Agenturets Udvalg for Lægemidler til Mennesker (CHMP) fremhævede, at Akynzeo var effektivt til at forhindre både de umiddelbare og forsinkede faser af kvalme og opkastning efter kemoterapi, og at lægemidlet har en gunstig sikkerhedsprofil.
English: A second main study looked at the benefits of Akynzeo in patients undergoing moderately emetogenic chemotherapy.
Danish: En anden større undersøgelse så på fordelene ved Akynzeo hos patienter, der gennemgik moderat emetogen kemoterapi.
English: Akynzeo contains the active substances netupitant and palonosetron.
Danish: Akynzeo indeholder de aktive stoffer netupitant og palonosetron.
English: In a main study comparing Akynzeo with palonosetron alone, 90% of patients taking Akynzeo (121 out of 135) experienced no vomiting within 5 days of starting highly emetogenic chemotherapy compared with 77% of patients taking palonosetron alone (104 out of 136).
Danish: I en større undersøgelse, der sammenlignede Akynzeo med palonosetron alene, oplevede 90 % af de patienter, der tog Akynzeo (121 ud af 135), ingen opkastning inden for 5 dage fra påbegyndelse af højemetogen kemoterapi, sammenlignet med 77 % af de patienter, der tog palonosetron alene (104 ud af 136).
English: Why is Akynzeo approved?
Danish: Hvorfor blev Akynzeo godkendt?
English: For more information about treatment with Akynzeo, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Akynzeo, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: It is not intended to provide practical advice on how to use Akynzeo.
Danish: Det er ikke en praktisk vejledning i, hvordan Akynzeo bør anvendes.
English: What is Akynzeo and what is it used for?
Danish: Hvad er Akynzeo, og hvad anvendes det til?
English: What are the risks associated with Akynzeo?
Danish: Hvilke risici er der forbundet med Akynzeo?
English: Some chemotherapy is known to induce severe nausea and vomiting, and Akynzeo is used in patients receiving either highly emetogenic (vomit-inducing) chemotherapy based on the cancer medicine cisplatin, or other chemotherapies that are moderately emetogenic.
Danish: Nogle kemoterapier er kendt for at give svær kvalme og opkastning, og Akynzeo anvendes hos patienter, der enten får kemoterapi, der er kraftigt kvalmefremkaldende (emetogen) baseret på cancerlægemidlet cisplatin eller andre kemoterapier, der er moderat emetogene.
English: The two active substances in Akynzeo work by blocking two different mechanisms involved in inducing nausea and vomiting during chemotherapy.
Danish: De to aktive stoffer i Akynzeo virker ved at blokere to forskellige mekanismer, der medvirker til at fremkalde kvalme og opkastning under kemoterapi.
English: Akynzeo is a medicine used to prevent nausea (feeling sick) and vomiting in adult patients with cancer who are receiving chemotherapy (medicines to treat cancer).
Danish: Akynzeo er et lægemiddel, der anvendes til at forebygge kvalme og opkastning hos voksne patienter med cancer, som modtager kemoterapi (lægemidler til behandling af cancer).
English: For practical information about using Akynzeo, patients should read the package leaflet or contact their doctor or pharmacist.
Danish: Hvis du ønsker praktisk vejledning om anvendelsen af Akynzeo, kan du læse indlægssedlen eller kontakte din læge eller dit apotek.
English: By having both active substances together, Akynzeo helps provide control for both the immediate and delayed phases of nausea and vomiting than occur following chemotherapy.
Danish: Ved at anvende begge aktive stoffer sammen hjælper Akynzeo med til at tilvejebringe kontrol af både de umiddelbare og forsinkede faser af kvalme og opkastning, der indtræffer efter kemoterapi.
English: How is Akynzeo used?
Danish: Hvordan anvendes Akynzeo?
English: receptors, which are found in the nervous system and are responsible for the delayed phase of nausea and vomiting (that occurs after the first 24 hours); palonosetron, on the other hand, blocks 5HT3 receptors in the gut, which are responsible for the immediate phase (that occurs within the first 24 hours).
Danish: Palonosetron blokerer på den anden side 5HT3-receptorerne i tarmsystemet, som er ansvarlige for den umiddelbare fase (der indtræffer inden for de første 24 timer).
English: What benefits of Akynzeo have been shown in studies?
Danish: Hvilke fordele viser undersøgelserne, at der er ved Akynzeo?
English: How does Akynzeo work?
Danish: Hvordan virker Akynzeo?
English: Netupitant works by blocking neurokinin-1 (NK1)
Danish: Netupitant virker ved at blokere neurokinin-1(NK1)-receptorerne, som findes i nervesystemet, og som er ansvarlige for den forsinkede kvalme- og opkastningsfase (der indtræffer efter de første 24 timer).
English: MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administra
Danish: MF (EU)-nummer (Særnavn) Navn
English: Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states
Danish: BILAG I Fortegnelse over lægemidlernes navne, lægemiddelformer, styrker, indgivelsesveje, indehavere af markedsføringstilladelser i medlemsstaterne
English: Kruczkowskiego 8 00-380 Warzawa Poland
Danish: Kruczkowskiego 8 00-380 Warszawa Poland
English: Beriplast and associated names Member State (in EEA)
Danish: Beriplast og tilhørende navne Medlemsstat (i EØS)
English: Artiss and associated names; Tisseel and associated names; Tissucol and associated names Member State (in EEA)
Danish: Artiss og tilhørende navne; Tisseel og tilhørende navne; Tissucol og tilhørende navne Medlemsstat (i EØS)
English: Aprotinin 15000 KIU;
Danish: Aprotinin 15000 KIE;
English: A- 1221 Vienna Austria
Danish: 1221 Vienna
English: Czech Republic Baxter Czech spol.
Danish: Baxter Czech spol.
English: Baxter Médico-Farmacêutica, Lda.
Danish: Médico-Farmacêutica, Lda.
English: United Kingdom Baxter Healthcare Limited, Caxton Way,
Danish: Storbritannien Baxter Healthcare Limited, Caxton Way,
English: The Netherlands Baxter AG Industriestraße 67
Danish: Luxembourg Baxter AG Industriestraße 67
English: Norfork IP24 3SE, United Kingdom
Danish: Norfolk IP24 3SE, United Kingdom
English: BERIPLAST P 0.5 ml, 1 ml, 3 ml, powders and solvents for sealant Combi-Set
Danish: P 0,5 ml, 1 ml, 3 ml, powders and solvents for sealant
English: CSL BEHRING 5 Hadjiyianni Mexi str, 11528-Athens Greece
Danish: Grækenland CSL BEHRING 5 Hadjiyianni Mexi str, 11528-Athens
English: Karla Engliše 3201/6
Danish: Karla Engliše 3201/6 150 00 Praha 5
English: Zona Industrial da Abrunheira - Edifício 10 - Sintra Business Park
Danish: Zona Industrial da Abrunheira - Edifício 10Sintra Business Park 2710-089 Sintra Portugal
English: Total Protein 200-260 mg;
Danish: Protein i alt 200-260 mg;
English: Norfork IP24 3SE,
Danish: Norfolk IP24 3SE,
English: Total Protein 500-650 mg;
Danish: Protein i alt 500-650 mg;
English: Human fibrinogen (clottable protein): 72-110 mg/ml
Danish: Humant fibrinogen (koagulerbart protein): 72-110 mg/ml
English: Baxter Medical AB, Isafjordstgatan 30B P.O.
Danish: Baxter Medical AB, Isafjordsgatan 30B P.O. Box 63
English: TISSEEL Lyo, TwoComponent Fibrin Sealant
Danish: TISSEEL Lyo, Two-Component Fibrin Sealant
English: Component Fibrin Sealant
Danish: Two-component Fibrin Sealant
English: Beriplast P CombiSet Pulver und Lösungsmittel für einen
Danish: Beriplast P Combi-Set Pulver und Lösungsmittel für einen Gewebekleber
English: Beriplast P CombiSet 1 ml prašek in vehikel za lepilo za tkiva
Danish: Combi-Set 1 ml prašek in vehikel za lepilo za tkiva
English: Beriplast P CombiSet 3 ml prašek in vehikel za lepilo za tkiva
Danish: Combi-Set 3 ml prašek in vehikel za lepilo za tkiva
English: Calcium chloride: 40 µmol/ml
Danish: Calciumchlorid: 40 µmol/ml
English: Tisseel - Lösungen für einen
Danish: Tisseel - Lösungen für einen Gewebekleber
English: Bottle 3: Human Thrombin 500 IU/ml;
Danish: Flaske 3: Humant thrombin 500 IE/ml;
English: Tisseel Lyo - Pulver und Lösungsmittel für einen
Danish: Tisseel Lyo - Pulver und Lösungsmittel für einen Gewebekleber
English: Factor XIII 30 a.e
Danish: Faktor XIII 10-50 IE;
English: The Netherlands Baxter B.V. Kobaltweg 49, Utrecht 3542 CE
Danish: Kobaltweg 49, 3542 CE Utrecht The Netherlands
English: Component 1
Danish: Komponent 1
English: Component 2
Danish: Komponent 2
English: 2nd Component: Thrombin 500 UI/ml
Danish: 2. komponent: Thrombin 500 IE/ml
English: Polígono Industrial Sector 14 Pouet de Camilo, 2
Danish: BAXTER, S.L.Polígono Industrial Sector 14 Pouet de Camilo, 2 46394 Ribarroja del Turia Valencia
English: Thrombin 1000 IU or Thrombin 8 UI; Calcium Chlorid Dihydrate 11.76 mg
Danish: Thrombin 1000 IE eller Thrombin 8 IE; Calciumchloriddihydrat 11,76 mg
English: ARTISS - Lösungen für einen
Danish: ARTISS - Lösungen für einen Gewebekleber
English: Beriplast P CombiSet 0,5ml/1ml/3ml
Danish: Combi-Set 0,5ml/1ml/3m l
English: Norfork
Danish: Norfolk
English: Thrombin 2500 IU or Thrombin 20 UI; Calcium Chlorid Dihydrate 29.4 mg
Danish: Thrombin 2500 IE eller Thrombin 20 IE; Calciumchloriddihydrat 29,4 mg
English: Calcium chloride: 40 µmol/ml Factor XIII: 30 IU/ml
Danish: Calciumchlorid: 40 µmol/ml Faktor XIII: ≤10 IE/ml
English: Component 1:
Danish: Komponent 1:
English: Clottable protein: 150-230 mg, thereof Fibrinogen 140-220 mg; Plasma Fibronectin 4-18 mg; Factor XIII 20-100 UI;
Danish: Koagulerbart protein: 150-230 mg, hvoraf fibrinogen 140-220 mg; Plasmafibronectin 4-18 mg;
English: Fibrinogen human 90,00 mg /ml Factor XIII : 10,00 UI/ml Fibronectin : 5,50 mg/ml Plasminogen : 0,08 mg/ml Aprotinin 3000,0 UIK*** /ml
Danish: Fibrinogen, humant 90,00 mg/ml Faktor XIII: 10,00 IE/ml Fibronectin: 5,50 mg/ml Plasminogen: 0,08 mg/ml Aprotinin 3000,0 KIE***/ml
English: Clottable protein: 375-575 mg, thereof Fibrinogen 350-550 mg; Plasma Fibronectin 10-45 mg; Factor XIII 50-250 UI;
Danish: Koagulerbart protein: 375-575 mg, hvoraf fibrinogen 350-550 mg; Plasmafibronectin 10-45 mg;
English: Thrombin S lyophilized: 500 I.E/ml Thrombin L lyophilized: 4 I.E/ml Calcium chloride: 5,88 mg/ml
Danish: Thrombin S lyofiliseret: 500 IE/ml Thrombin L lyofiliseret: 4 IE/ml Calciumchlorid: 5,88 mg/ml
English: 1st Component:
Danish: 1. komponent:
English: Component 2:
Danish: Komponent 2:
English: Thrombin 500 IU or Thrombin 4 UI; Calcium Chlorid Dihydrate 5.88 mg
Danish: Thrombin 500 IE eller Thrombin 4 IE; Calciumchloriddihydrat 5,88 mg
English: Cutaneous Use
Danish: Kutan anvendelse
English: Thrombin (human) 500 I.E./ml Calcium chloride: 5,88 mg/ml
Danish: Thrombin (humant) 500 IE/ml Calciumchlorid: 5,88 mg/ml
English: 150 00 Praha 5
Danish: Tissucol Duo 500
English: Proteins 50mg/ml; Bottle 4: Human Thrombin 4 UI/ml; Proteins 50mg/ml;
Danish: Proteiner 50 mg/ml; Flaske 4: Humant thrombin 4 IE/ml; Proteiner 50 mg/ml; Flaske 5: calciumchlorid 40 µmol/ml
English: BAXTER HELLAS LTD 3 Metsovou str, 14121-N Irakleio, Athens
Danish: Grækenland BAXTER HELLAS LTD 3 Metsovou str,
English: 2nd Component:
Danish: 2. komponent:
English: TISSUCOL Kit 1,0 kétkomponensű fibrinragasztó
Danish: Kit 1,0 kétkomponensű fibrinragasztó
English: Powder, solution and solvent for sealant
Danish: Pulver, opløsning og solvens til vævsklæber
English: Human fibrinogen: 90 mg Coagulation factor XIII: 60 UI Aprotinin: 1000 KUI Trombin: 7,6 mg Calcium chloride: 5,9 mg
Danish: Human fibrinogen: 90 mg Koagulationsfaktor XIII: 60 UI Aprotinin: 1000 KUI Trombin: 7,6 mg Calcium chloride: 5,9 mg
English: Fibrinogen: 72-110mg/ml Aprotinin: 3000KIU/ml Thrombin: 500 IU/ml in 45-55mg total protein
Danish: Fibrinogen: 72-110 mg/ml Aprotinin: 3000 KIE/ml Thrombin: 500 IE/ml i 45-55 mg protein i alt
English: TISSUCOL Kit 2,0 kétkomponensű fibrinragasztó
Danish: Kit 2,0 kétkomponensű fibrinragasztó
English: TISSUCOL Kit 5,0 kétkomponensű fibrinragasztó
Danish: Kit 5,0 kétkomponensű fibrinragasztó